Labeler · US market

Cameron Pharmaceuticals

Cameron Pharmaceuticals is a US drug labeler with US FDA registrations covering 6 drug concepts (4 currently active) across 17 packages. It is currently the only active US supplier of 1 drug.

ACTIVE — US

openFDA · updated weekly

Labeler codes42494

Active drugs4

Registrations10 active / 13

Packages17

Sole supplier of1 drugs

Portfolio6 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Phenobarbital Sodium injection	rx	4	6	SUPPLYING
Vancomycin Hydrochloride capsule	rx	2	4	SUPPLYING
Acetylcysteine solution	rx	2	2	SUPPLYING
Entecavir Anhydrous tablet	rx	2	2	SUPPLYING
Naproxen tablet	rx	2	2	DISCONTINUED
Carboxymethylcellulose Sodium, Unspecified solution/ drops	otc	1	1	DISCONTINUED

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

Entecavir Anhydrousrx

At a glance

TypeLabeler
Labeler codes42494
Filing names1
Drugs (active)4
Drugs (all time)6
US registrations13
Packages17

Recent events

Shortages, recalls, and registration changes across all filing names.

Mar 14, 2022
RECALLRecall (Class II): PHENOBARBITAL Sodium Injection, USP, 65mg/mL, packaged as a) 25 x 1 mL Vials per box (NDC 42494-415-25) and b) 3 x 1 mL…
Mar 14, 2022
RECALLRecall (Class II): PHENOBARBITAL Sodium Injection, USP, 130 mg/mL, packaged as a) 25 x 1 mL Vials per box (NDC 42494-416-25) and b) 3 x 1m…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.